In a new study published in Nature, scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria ...
Transmission electron micrograph of HIV-1 virus particles (blue) from infected H9 cells, produced in cell culture. The particles exhibit two stages of replication: the two “arcs” are immature ...
SAN FRANCISCO, Oct. 17, 2019 /PRNewswire/ -- Amygdala Neurosciences (a private company) announced today the start of dosing in the National Institute on Alcohol Abuse and Alcoholism (NIAAA, an ...
The National Institutes of Health (NIH) has launched a proof-of-concept precision medicine clinical trial to test new treatment combinations targeting specific genetic changes in the cancer cells of ...
Three different HIV antibodies each independently protected monkeys from acquiring simian-HIV (SHIV) in a placebo-controlled proof-of-concept study intended to inform development of a preventive HIV ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback